TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

OCT, optical coherence tomography, coronary stent implantation, superior resolution, TCT 2016, ILLUMIEN III OPTIMIZE PCI Trial
News | Optical Coherence Tomography (OCT) | October 31, 2016
October 31, 2016 — Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing...
EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD
Feature | Stents Drug Eluting | October 31, 2016
October 31, 2016 — A major international study has found that drug-eluting stents, a less-invasive alternative to...
Mitralign, Trialign tricuspid repair system, SCOUT I study, 30-day data, TCT 2016
News | Heart Valve Technology | October 28, 2016
October 28, 2016 — Mitralign will present data on its Trialign Tricuspid Repair system at the 2016 Transcatheter...
Svelte Medical Systems, CE Mark, Direct RX, Direct sirolimus-eluting coronary stent rapid exchange system, drug-eluting stent, DES
News | Stents | October 28, 2016
October 28, 2016 — Svelte Medical Systems Inc. announced this week it received CE Mark certification of the Direct...
tryton side branch stent, bifurcation stenting, Cardinal Health
News | Stents Bifurcation | October 28, 2016
October 28, 2016 – Tryton Medical Inc., a primary developer of stents to treat coronary bifurcation lesions, and...
Corindus, Corpath, robotic navigation, Robotic PCI, CorPath GRX
Technology | October 27, 2016
October 27, 2016 — Corindus Vascular Robotics Inc. announced it received 510(k) clearance from the U.S. Food and Drug...
Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics
Feature | Cath Lab | October 27, 2016 | Dave Fornell
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT)...
BioTrace Medical Tempo temporary pacing lead, TAVR
Technology | Heart Valve Technology | October 27, 2016
October 27, 2016 — BioTrace Medical Inc. said it received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Philips, TCT 2016, image guidance technologies, iFR, HeartNavigator
News | Cath Lab | October 26, 2016
October 26, 2016 — Philips recently announced its latest image guidance solutions to be featured at the 2016...
HawkOne atherectomy system
Technology | Atherectomy Devices | October 24, 2016
October 24, 2016 — Medtronic received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne ...
bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system

 

Feature | Stents Bioresorbable | October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular...
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices | October 20, 2016
October 20, 2016 — Avinger Inc. recently announced that the company has received expanded indications from the U.S....
St. Jude Medical, PressureWire X Guidewire, FDA, launch, FFR catheter
Technology | FFR Technologies | October 10, 2016
October 10, 2016 — St. Jude Medical Inc. announced the U.S. clearance and launch of the company’s new PressureWire X...
Xeltis bioabsorbable valve implant, two-year data, EACTS 2016
News | Heart Valve Technology | October 06, 2016
October 6, 2016 — Xeltis announced this week that patients implanted with its bioabsorbable cardiovascular conduit...
Xeltis bioabsorbable pulmonary heart valve, Xplore-I clinical feasibility study, first pediatric implants, EACTS 2016
News | Heart Valve Technology | October 04, 2016
October 4, 2016 — Xeltis recently announced that three pediatric patients have been successfully implanted with the...